Cited by 234Liver physiology and pathologyCancer-related Molecular PathwaysDevelopmental Biology and Gene Regulation

Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.

Open access
Wu, H, Wade, M, Krall, L, Grisham, J, Xiong, Y, Van Dyke, T·1996·Genes & Development

Abstract

The CDK inhibitor p21 (WAF-1/CIP-1/SDI-1) has been implicated in DNA damage-induced p53-mediated G1 arrest, as well as in physiological processes, such as cell differentiation and senescence, that do not involve p53 function. To determine the impact of p21 on normal development and cell-cycle regulation in vivo, we have generated transgenic mice that abundantly express p21 specifically in hepatocytes. During postnatal liver development, when transgenic p-21 protein becomes detectable, hepatocyte proliferation is inhibited dramatically. This disturbance causes a reduction in the overall number of adult hepatocytes, resulting in aberrant tissue organization, runted liver and body growth, and increased mortality. The transgenic p21 protein is associated with most, if not all, of the cyclin D1-CDK4 in liver but not significantly with other cyclin/CDK proteins, indicating the importance of cyclin D1-CDK4 function in normal liver development. The appearance of large polyploid nuclei in some hepatocytes indicates that p21 may also cause arrest during the G2 phase of the cell cycle. Significantly, partial hepatectomy failed to stimulate hepatocytes to proliferate in p21 transgenic animals. These results provide the first in vivo evidence that appropriate p21 levels are critical in normal development and further implicate p21 in the control of multiple cell-cycle phases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.10.3.245

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The proliferation of p21 positive hepatocytes is irreversibly inhibited, making it unlikely that p21 positive hepatocytes contribute to regeneration here.

    “The proliferation of p21 positive hepatocytes is irreversibly inhibited49 making it unlikely that p21 positive hepatocytes contribute to regeneration here.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y., & Van Dyke, T.
Affiliations
University of North Carolina at Chapel Hill (US)
Venue
Genes & Development
Published
1996-02-01
Volume
10
Issue
3
Pages
245-260
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W4300612151
Cited by
234
References
75
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 4 · 2015: 5 · 2014: 2 · 2013: 4 · 2012: 1
Type
posted content
Language
en
Open access
Locations
  • Genes & Development (publishedVersion)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • National Institutes of Health (5r01dk042910-04)
  • National Cancer Institute (R01CA065572, CA 65572, R01CA046283, CA-46283)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-42910)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
p21, cyclin-dependent kinase inhibitors, hepatocytes, postnatal liver development, liver regeneration, cell cycle arrest, cyclin D1/CDK4, hepatocyte proliferation, transgenic mice, partial hepatectomy, G2 cell cycle arrest, polyploidy, p53-independent function
MeSH terms
Animals, Base Sequence, Cell Cycle, Cell Division, DNA, Enzyme Inhibitors, Hepatectomy, Liver, Liver Regeneration, Mice, Transgenic, Molecular Sequence Data, Prealbumin, Proto-Oncogene Proteins, Oncogene Proteins, Cyclins, Gene Targeting, Cyclin-Dependent Kinases, Cyclin D1, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 4, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review